Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Short selling, legal or naked, will not be able to prevent NWBO's eventual success. Check out "The Economics of Naked Short Selling" from an SEC publication at www.cato.org › regulation › spring-2008. I'll probably wait until 2020 to sell.
Senti - After reading Smith on Stocks' blog today (Illegal Naked Short Selling Appears to Lie at the Heart of an Extensive Stock Manipulation Scheme), I am quite certain that this illegal business will continue until FDA approval. Larry Smith's indepth examination is quite shocking and a must read. Thx for all your truthul contributions.
Good point, but we all agree that cancer vaccines are asynchronous. And like you said, with a six-patient sample, statistical significance can't be had. Cheers.
Great news! Thanks for posting.
I agree. I sure hope a stock buyback is performed instead of or in addition to a reverse split in order to soften the blow to shareholders. Official news of the international bank contract will be most welcome, too.
Thank you very much for your in depth balancing comments. - A biased long.
Hi Pyr, A question from someone new to biotech and the FDA's clinical trials:
As you well know from clinicaltrials.gov, the DCVax-Direct Ph I/II trial design has been designed as follows:
? Primary Outcome Measure.: Adverse events (6 months) ~ safety.
? Secondary Outcome Measure: Tumor Response (18 months) ~ sum of partial and complete responses.
? Other Outcome Measures: # of Patients Surviving AND # of Patients Surviving w/o Tumor Progression (24 months).
If phase II trial results related to the secondary outcome measurement involving ORR and RECIST are borderline or fall short (your recent concerns) but are adaquate related to one of the other outcome measures, is it likely that NWBO will receive the go ahead for Phase III anyway?
Thank you.
I believe NWBO's simultaneous U.S.-European stategy limits Big Pharma's influence on the FDA.
Having a 401k prevents me from feeling like a schmuck. ;)
Some live much longer than the average you reference. I think that hope would attract most who had the means to pay or be reimbursed.
I pulled this information from the clinicaltrials.gov website:
MD Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contact: Quan Lin 713-792-6073 qdlin@mdanderson.org
Contact: Patient Access Center 713-792-1160
Principal Investigator: Vivek Subbiah, MD
I would advise sending an email in addition to calling the telephone numbers.
You are not alone. My wife is at MD Anderson right now being treated for cervical cancer; however, she wasn't eligible for the Direct trial. I pray that your husband is admitted into the trial and that the DCVax-Direct platform cures all the cancer.
That's right. Investors don't need the FDA (and SEC) to fly staight, but all the American cancer patients do. And the latter is a more important reason for longs not to bail or lose hope due to recent decline in pps. Big pharma execs, hedge fund mrgs, many shorts, etc. are in the businees of attacking good science and deceiving people; however, they are the ones who are being deceived. The irony is astounding.
Very nice. Very very nice.
Remnants of the countless scumbags in Napster's chat rooms.
Depending on the extent of reducing ones position, in a way, selling at this point may require even more risk given the various means by which the stock could substantially increase prior to unknowns being answered.
Aug. 6, 2014 article (http://www.huffingtonpost.com/paul-sanderson/30-stars-and-doctors-sign_b_5652713.html) mentions Dr. Linda Liau, but not NWBO. The link was posted on Yahoo's dashboard, but then was mysteriously removed from the graphic lineup.
I agree wholeheartedly.
Malicious shorts must be haunted with anxiety as to whether or not their lies will succeed in making them money in the short run. On the other hand, long term investors simply remain faithful to the truth we discovered. Longs, be patient and don't worry about ANYTHING. That doesn't mean we should lay down when attacked. I just want to encourage everyone not to worry. I am very confident, like many of you, that NWBO will succeed.
New negative article was just posted on Seeking Alpha.
Headline: "Mr. TORbachav, tear down this sticky note."
More bad journalism. On June 11, 2014, Benzinga's Morning Market Makers reported, "Northwest Biotherapeutics (NASDAQ: NWBO) shares gained 6.82% to $6.12 after the company reported positive outcome of Phase IIIb COMPASS Trial." On June 10, 2014, The Wall Street Journal stated, "Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine."
Today I confirmed with TDAmeritrade that non-margined NWBO shares are not available to short. It's automatic; special requests aren' t needed.
You were right the first time. It's an issue of direct quotations vs. reported speech. You've taught me so much on this board, I felt I owed it to you. Check out http://www.edufind.com/english/grammar/reported_speech.php. Go NWBO!
I saw the same spread and put in limit order for block of shares at 6.10. It was filled at 5.99. After hearing of your purchase, I'll know better next time. Thanks for sharing.
My friend Dave is at M.D. Anderson in Houston having been referred by his PCP last week. This doctor told him that there are two kinds of melanoma. One that generally moves laterally and one that tends to go deeper. Fortunately, he has the former. He emailed me their plan in Houston: after the oncologist removes more tissue where the legion on his back was, he is going to remove a nearby lymph node for testing. If the pathology on the node is clear, he'll be good to go.
Possible scenario: ASCO fails, L succeeds. Another possible scenario: ASCO flops, and Direct still succeeds. Wait til the fat lady sings before you dump your shares.
Again, "Why is there a data embargo prior to ASCO if companies aren't permitted to present the data there?" Very Long.
A Biotech King, Dethroned
2013/09/06 03:37
David Blech, who was once biotechnology’s top gunslinger and was worth about $300 million, is about to begin a four-year prison term, having pleaded guilty to stock manipulation.
Long, Your statement begins, "ALL the latest news...". That is a false statement. You are a liar and suffering from the bondage of journalistic whoredom. Seek the truth and it will set you free. YOU called Linda slimy. You are projecting your own problems on her and NWBO. I am glad you are not long. People like you don't deserve to benefit from the work of good people.
Pyr, Thanks for Post 6599. You are a good moderator.
Doc, vgraessle@yahoo.com. Thank you.
I respect that. You can't be too careful these days. I don't post much, but this board played a large part in my DD which resulted in a lopsided investment portfolio a year ago. With so many family members and friends succumbing to or fighting with cancer, even in the unlikely event we fail, I won't regret taking the risk and joining NWBO in their efforts to help those with this dreaded disease. God bless NWBO. Amen.
1. Not everyone wants to buy more shares.
2. Even if someone did, it wouldn't necessarily preclude them from filing a complaint.
3. Matters of business ethics and laws can be pursued without regards to pps and the desire to accumulate.
4. When I read your post, I just wanted to reach through my PC and flick you in the eyeball as you drool over pps issues like many of those on YB. Sound familiar? Those were some of your words on this board not long ago.
5. Don't be such a hypocrite.
Doc, If you (or anyone else) has filed a complaint with the SEC re: AF, can I get a copy to use as a template for my own letter. Thx
Pyrr, That comment is wrong on so many levels.
LOL. Buy low sell high. You figured it out.
I am an amateur investor with a regular TDAmeritrade account. How does a person get the most updated pre-market quotes in the early morning? I would be willing to subscribe to a service if necessary. Thank you for your contributions to IH.
I think their website was improved with more information and graphics. So it's new in that sense. Someone please correct me if I'm wrong.
Feurerstein's arguement is careless. The recent PR from NWBO clearly explains the difference between NWBO's DCVax and IMUC's ICT-107. He obviously could not use this source of information in his short rant of hyperbole.
Ou, your strategy makes sense - a wise hedge that covers at least some of the NWBO stake should something unforseen arise.